<DOC>
	<DOCNO>NCT02661217</DOCNO>
	<brief_summary>To explore two modality treatment initiation ( Pre-discharge , Post-discharge ) LCZ696 HFrEF patient follow stabilization ADHF episode .</brief_summary>
	<brief_title>Comparison Pre- Post-discharge Initiation LCZ696 Therapy HFrEF Patients After Acute Decompensation Event</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>LCZ 696</mesh_term>
	<criteria>1 . Patients hospitalize due acute decompensated HF episode ( ADHF ) primary diagnosis ) consistent Signs &amp; Symptoms 2 . Diagnosis HF New York Heart Association class IItoIV reduce ejection fraction : Left ventricular ejection fraction ≤ 40 % Screening 3 . Patients receive IV vasodilator ( except nitrate ) , and/or IV inotropic therapy time presentation ADHF Randomization 4 . Stabilized ( hospital ) least 24 hour lead Randomization . 5 . Meeting one follow criterion : Patients dose ACEI ARB screen ACEI/ARB naïve patient patient ACEI ARB least 4 week screen . 1 . History hypersensitivity sacubitril , valsartan , ARBs , NEP inhibitor LCZ696 excipients . 2 . Symptomatic hypotension and/or SBP 110 mm Hg SBP 180 mm Hg prior randomization 3 . End stage renal disease Screening ; estimate GFR 30 mL/min/1.73 m2 ( measure MDRD formula Randomization . 4 . Serum potassium 5.4 mmol/L Randomization . 5 . Known history hereditary idiopathic angioedema angioedema relate previous ACE inhibitor ARB therapy 6 . Severe hepatic impairment , biliary cirrhosis cholestasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Acute decompensated heart failure , reduce ejection fraction , pre-discharge treatment , post-discharge treatment , angiotensin receptor neprilysine inhibitor .</keyword>
</DOC>